RIENSO

This brand name is authorized in Estonia, Lithuania.

Active ingredients

The drug RIENSO contains one active pharmaceutical ingredient (API):

`1`	Ferumoxytol UNII `CLH5FT6412` - FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE
	Ferumoxytol (USAN) is a dark-brown substance, which consists of nano-sized super paramagnetic iron (III)-oxide-cores coated with a small-sized carbohydrate shell of polyglucose sorbitol carboxymethylether (PSC).
	Read more about Ferumoxytol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1588811, 1588822, 1598014, 1598025
LT	Valstybinė vaistų kontrolės tarnyba	1066909, 1066910, 1068403, 1068404

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.